Homepage
Open in app
Sign in
Get started
Variant Bio
About Us
All Posts
Tagged in
Drug Discovery
Variant Bio
Variant Bio is developing therapies that will improve global health by studying the genes of people who are outliers for medically relevant traits.
More information
Followers
133
Elsewhere
More, on Medium
Drug Discovery
Sarah LeBaron von Baeyer, PhD
in
Variant Bio
Oct 8
Spotlight on R&D: Science is Not a Solo Act
How Stacey Drabic, Variant Bio’s VP of Biology, works…
Read more…
Olivia Gray
in
Variant Bio
Sep 12
The Power of Multi-Omics in Global Genomic Research
Read more…
1
Luan Phan
in
Variant Bio
Jul 23
A Look Inside the Lab at Variant Bio
Luan Phan, from Variant Bio’s R&D team, discusses his work on…
Read more…
5
André Singer
in
Variant Bio
Jun 20
Reflections from BIO International Convention 2024: Paving New Pathways in Biotech
Read more…
3
David Purdy
in
Variant Bio
May 8
Spotlight on R&D: Inside the World of DMPK
The importance of optimizing compounds’ design and…
Read more…
7
RC Chin-Wen Lai
in
Variant Bio
Apr 22
A Passion for Both Scientific Inquiry and Environmental Sustainability
Read more…
3
Andrew Farnum
in
Variant Bio
Apr 18
Evotec and Variant Bio Enter Strategic Partnership to Discover and Develop Fibrosis Treatments
Read more…
Todd Meyer
in
Variant Bio
Apr 9
Spotlight on R&D: From Molecules to Medicines
Chemists on Variant Bio’s R&D team are discovering new…
Read more…
Sarah LeBaron von Baeyer, PhD
in
Variant Bio
Mar 21
Spotlight on Variant Bio’s Ethics Advisory Board: An Interview with Misha Angrist
Read more…
1
Sarah LeBaron von Baeyer, PhD
in
Variant Bio
Feb 8
Inside Variant Bio: Highlighting the Work of Women in R&D
Read more…
1